ST中珠公告称，公司股东深圳市众生源企业管理中心（有限合伙）因自身资金需求，计划减持不超过公司总股本3%的股份。此次减持将通过集中竞价及大宗交易方式进行。另据维康药业公告，其产品感冒清热颗粒已成功中选国家中成药集采。 AI
排序理由 该条目是多个不相关新闻的摘要，没有单一占主导地位的与AI相关的新闻。
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
ST中珠股东拟减持不超过3%股份，维康药业感冒清热颗粒中选集采
本文如何被排名
- Signal score
- 0 / 100
- Composite score across the factors below. Higher = stronger signal that this story matters right now.
- Newsworthiness bucket
- Meme
- 该条目是多个不相关新闻的摘要，没有单一占主导地位的与AI相关的新闻。
- Source corroboration
- Single-source cluster
- Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
- Topics
- other
- Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
- AI-industry relevance
- Low
- Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
- Story freshness
- 77 days old
- Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.
完整方法见我们的编辑标准。
报道来源 [1]
-
ST中珠：股东拟减持公司股份不超3%
36氪获悉，ST中珠公告，股东深圳市中盛源企业管理中心（有限合伙）因自身资金需求，拟通过集中竞价和大宗交易方式减持所持有的不超过5978.61万股公司股票，占公司总股本比例不超过3%。